在史密斯-莱姆利-奥皮茨综合征 (SLOS) 模型中,氧对后兰醇生物合成的影响
Zeljka Korade1, Allison C Anderson2, Marta Balog2,3
1Department of Pediatrics, Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Child Health Research Institute, Omaha, NE 68198, USA.
Biomolecules
|April 30, 2025
概括
氧 (HYZ) 在史密斯-莱姆利-奥皮茨综合征 (SLOS) 模型中可以抵消7-脱胆固醇 (7-DHC) 积累. 然而,HYZ公司的
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
背景情况:
- 史密斯-莱姆利-奥皮茨综合征 (SLOS) 是一种罕见的发育障碍,由7-脱胆固醇减少酶 (DHCR7) 酶的致病变体引起.
- 这种酶缺乏导致7-脱胆固醇 (7-DHC) 的积累,后者氧化成细胞毒性氧化醇,导致疾病病理.
研究的目的:
- 调查通过高通量选确定的氧 (HYZ) 的潜力,以减轻SLOS中的7-DHC积累.
- 在各种SLOS模型中评估HYZ对后兰醇生物合成的生化影响.
主要方法:
- 利用了缺少Dhcr7的Neuro2a细胞,来自Dhcr7T93M/T93M转基因小鼠的神经元和质细胞培养物,以及来自SLOS患者的人类皮肤纤维细胞.
- 采用液体染色学-双重质谱法 (LC-MS/MS) 进行细致的固醇中间体的生物化学分析.
主要成果:
- 在所有测试的SLOS模型中,氧氨酸对后兰醇生物合成产生调节作用.
- 在特定模型中观察到7-DHC和其他中间体的显著减少,但在多个类固醇分析物中也观察到复杂的,剂量依赖的和可变的变化.
- 人体纤维细胞显示7-DHC,7-dehydrodesmosterol (7-DHD) 和dihydrolanosterol (DHL) 的降低,同时增加了zymosterol (ZYM),zymostenol (ZYME) 和8-dehydrocholesterol (8-DHC) 的增加.
结论:
- 氧在SLOS模型中影响了固醇生物合成,减少了像7-DHC.这样的关键病原性中间体.
- 复杂和可变的生化反应需要进一步研究,以确定HYZ在SLOS中的净治疗益处.
- 未来的研究应该评估观察到的有害固醇的减少是否被其他潜在有害中间体的增加所抵消.
更多相关视频
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
132
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
132
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
473
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
473
Antiepileptic Drugs: Potassium Channel Activators
134
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
134
Antiasthma Drugs: Leukotriene Modifiers
172
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
172
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
120
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
120
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
9.7K
Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.
9.7K


